Johnson & Johnson (N:JNJ)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Arvinas (OQ:ARVN)
Emergent Biosolutions (N:EBS)
Latest 10 SEC filings (by transaction date) for JNJ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Dec 17/18 Dec 14/18 Mulcahy Anne M Direct Ownership Common Stock P - Open market or private purchase 748 $133.76
Dec 17/18 Dec 14/18 Perez William D Direct Ownership Common Stock P - Open market or private purchase 1,000 $133.91
Dec 17/18 Dec 14/18 Prince Charles Direct Ownership Common Stock P - Open market or private purchase 2,000 $134.37
Dec 14/18 Dec 13/18 Kapusta Ronald A Direct Ownership Common Stock S - Open market or private sale -3,643 $147.31
Dec 13/18 Dec 11/18 Williams Ronald A Direct Ownership Deferred Share Units A - Grant, award or other under Rule 16b-3(d) 350  
Dec 13/18 Dec 11/18 Washington A. Eugene Direct Ownership Deferred Share Units A - Grant, award or other under Rule 16b-3(d) 307  
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -27,160  
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Common Stock S - Open market or private sale -41,563 $146.68
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 14,403 $90.44
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 27,160 $100.06
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for JNJ within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Dec 17/18 Dec 14/18 Mulcahy Anne M Direct Ownership Common Stock P - Open market or private purchase 748 $133.76
Dec 17/18 Dec 14/18 Perez William D Direct Ownership Common Stock P - Open market or private purchase 1,000 $133.91
Dec 17/18 Dec 14/18 Prince Charles Direct Ownership Common Stock P - Open market or private purchase 2,000 $134.37
Dec 14/18 Dec 13/18 Kapusta Ronald A Direct Ownership Common Stock S - Open market or private sale -3,643 $147.31
Dec 13/18 Dec 11/18 Williams Ronald A Direct Ownership Deferred Share Units A - Grant, award or other under Rule 16b-3(d) 350  
Dec 13/18 Dec 11/18 Washington A. Eugene Direct Ownership Deferred Share Units A - Grant, award or other under Rule 16b-3(d) 307  
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -27,160  
Dec 6/18 Dec 3/18 Fasolo Peter Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -77,213  
Dec 6/18 Dec 3/18 Fasolo Peter Direct Ownership Employee Stock Options (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -47,919  
Dec 6/18 Dec 4/18 Fasolo Peter Direct Ownership Common Stock S - Open market or private sale -41,563 $146.68
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $JNJ

StockTwits